Preclinical pharmacology of CP-424,391, an orally active pyrazolinone-piperidine [correction of pyrazolidinone-piperidine] growth hormone secretagogue.
暂无分享，去创建一个
S. Toler | D. Thompson | B. Lefker | J. A. Ragan | D. Tess | D. Maclean | D. Nettleton | J. Pettersen | D. Nickerson | L. Pan | P. Carpino | C. Pirie | B. Lu | P. DaSilva-Jardine | M. A. Mullins | K. Chidsey-Frink | O. Ng